BACKGROUND: Posterior Reversible Encephalopathy Syndrome (PRES) is a clinico-radiological entity characterized by headache, encephalopathy, visual disturbances, and seizures in association with reversible vasogenic edema on neuroimaging. Intracerebral hemorrhage associated with PRES (PRES-ICH) is generally considered an atypical finding. METHODS: Retrospective case series. RESULTS: Seven patients were identified with PRES-ICH, four males and three females. The presenting clinical symptoms included headache (2), encephalopathy (5), vision changes (2), seizures (2), and hemiparesis (1). The co-morbid conditions included acute renal dysfunction (3), solid organ transplantation (3), bone marrow transplant (1), use of calcineurin inhibitor agents (4), and pre-eclampsia (1). Neuroimaging revealed intraparenchymal hemorrhage in six patients and subarachnoid hemorrhage in one patient. Six of the seven patients with PRES-related ICH had underlying bleeding diathesis, including one patient who was anti-coagulated with a heparin drip. The mean platelet count was 82.1 x 10(3)/microl (range, 4-232 x 10(3)/microl), and the mean INR value was 2.18 (range, 0.9-6.7). Two patients died during the acute hospitalization. Among the five survivors, only two patients had good functional outcome (pre-defined as mRS < or = 1). CONCLUSION: In our series, the majority of patients with PRES-ICH (85%) had an underlying bleeding diathesis or coagulopathy. Although PRES is typically considered to have a favorable prognosis, the clinical outcome of PRES with associated ICH can be more variable.
BACKGROUND: Posterior Reversible Encephalopathy Syndrome (PRES) is a clinico-radiological entity characterized by headache, encephalopathy, visual disturbances, and seizures in association with reversible vasogenic edema on neuroimaging. Intracerebral hemorrhage associated with PRES (PRES-ICH) is generally considered an atypical finding. METHODS: Retrospective case series. RESULTS: Seven patients were identified with PRES-ICH, four males and three females. The presenting clinical symptoms included headache (2), encephalopathy (5), vision changes (2), seizures (2), and hemiparesis (1). The co-morbid conditions included acute renal dysfunction (3), solid organ transplantation (3), bone marrow transplant (1), use of calcineurin inhibitor agents (4), and pre-eclampsia (1). Neuroimaging revealed intraparenchymal hemorrhage in six patients and subarachnoid hemorrhage in one patient. Six of the seven patients with PRES-related ICH had underlying bleeding diathesis, including one patient who was anti-coagulated with a heparin drip. The mean platelet count was 82.1 x 10(3)/microl (range, 4-232 x 10(3)/microl), and the mean INR value was 2.18 (range, 0.9-6.7). Two patients died during the acute hospitalization. Among the five survivors, only two patients had good functional outcome (pre-defined as mRS < or = 1). CONCLUSION: In our series, the majority of patients with PRES-ICH (85%) had an underlying bleeding diathesis or coagulopathy. Although PRES is typically considered to have a favorable prognosis, the clinical outcome of PRES with associated ICH can be more variable.
Authors: H Kitaguchi; H Tomimoto; Y Miki; A Yamamoto; K Terada; H Satoi; M Kanda; H Fukuyama Journal: Neuroradiology Date: 2005-06-10 Impact factor: 2.804
Authors: C Horbinski; W S Bartynski; E Carson-Walter; R L Hamilton; H P Tan; S Cheng Journal: AJNR Am J Neuroradiol Date: 2008-10-14 Impact factor: 3.825
Authors: Alexander M McKinney; James Short; Charles L Truwit; Zeke J McKinney; Osman S Kozak; Karen S SantaCruz; Mehmet Teksam Journal: AJR Am J Roentgenol Date: 2007-10 Impact factor: 3.959
Authors: Tom K Gallagher; Kathryn A Thomas; Daniela P Ladner; Daniel Ganger; Farzaneh A Sorond; Shyam Prabhakaran; Michael M Abecassis; Jonathan P Fryer; Eric M Liotta Journal: Transplantation Date: 2018-03 Impact factor: 4.939
Authors: Andrew D Schweitzer; Neal S Parikh; Gulce Askin; Ajay Nemade; John Lyo; Sasan Karimi; Anna Knobel; Babak B Navi; Robert J Young; Ajay Gupta Journal: Neuroradiology Date: 2017-03-13 Impact factor: 2.804
Authors: Vivien H Lee; Richard E Temes; Sayona John; James J Conners; Thomas Bleck; Shyam Prabhakaran Journal: Neurocrit Care Date: 2013-02 Impact factor: 3.210